Recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis NCT06047379 Conditions Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more Locations Precision NextGen Oncology — Beverly Hills, California, United States OPN Healthcare, Inc — Glendale, California, United States University of Southern California — Los Angeles, California, United States MDR Core Network — Boynton Beach, Florida, United States View more locations Show fewer locations Loading locations... View Trial Details
Recruiting PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas NCT05190172 Conditions Astrocytoma, Diffuse Astrocytoma, IDH-Mutant, Glioma, +9 more Locations Oslo University Hospital — Oslo, Norway View Trial Details
